Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Whitehawk Therapeutics

Market Cap: US$89.1m

An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

XBiotech

Market Cap: US$82.0m

A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.

Nextleaf Solutions

Market Cap: CA$11.8m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Ginkgo Bioworks Holdings

Market Cap: US$623.5m

Develops a platform for cell programming in the United States.

Relief Therapeutics Holding

Market Cap: CHF 40.0m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.

SoftOx Solutions

Market Cap: NOK 187.2m

Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.

Alkermes

Market Cap: US$4.5b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Lexicon Pharmaceuticals

Market Cap: US$487.0m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

Apontis Pharma

Market Cap: €91.2m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Intervacc

Market Cap: SEK 348.3m

Develops novel veterinary vaccines for animals in Sweden.

Chongqing Pharscin Pharmaceutical

Market Cap: CN¥6.8b

Chongqing Pharscin Pharmaceutical Co., Ltd.

Edgewise Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Acutaas Chemicals

Market Cap: ₹111.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Stella Pharma

Market Cap: JP¥12.4b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Medicalsystem Biotechnology

Market Cap: CN¥3.9b

Engages in the research, development, production, and sales of in vitro diagnostic products in China.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥16.1b

Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.

Yili Chuanning BiotechnologyLtd

Market Cap: CN¥24.1b

Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.

Simcere Pharmaceutical Group

Market Cap: HK$32.4b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Guizhou Xinbang Pharmaceutical

Market Cap: CN¥6.5b

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.

Emyria

Market Cap: AU$39.8m

Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.

NATCO Pharma

Market Cap: ₹147.0b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

Inner Mongolia Furui Medical Science

Market Cap: CN¥20.0b

Inner Mongolia Furui Medical Science Co., Ltd.

Shanxi Zhendong PharmaceuticalLtd

Market Cap: CN¥6.5b

Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.

NanoEntek

Market Cap: ₩111.7b

Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.

Lincoln Pharmaceuticals

Market Cap: ₹10.8b

Engages in manufacturing and trading of pharmaceutical products in India.

Amplia Therapeutics

Market Cap: AU$77.0m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

Enzychem Lifesciences

Market Cap: ₩86.1b

Engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.

United Laboratories International Holdings

Market Cap: HK$29.2b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Grand Pharmaceutical Group

Market Cap: HK$29.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Jiangsu Kanion PharmaceuticalLtd

Market Cap: CN¥8.5b

Researches and develops, produces, and sells Chinese medicines.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

Newland Pharmaceutical

Market Cap: CN¥5.0b

Engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China.

Kotra Industries Berhad

Market Cap: RM 627.4m

An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.

Genovate Biotechnology

Market Cap: NT$2.6b

Engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan.

Joinn Laboratories(China)Co.Ltd

Market Cap: CN¥25.4b

Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥66.6b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.